Wayne Furr, MD
Obstetrics & Gynecology · Lonetree, CONPI 1316011885
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $104,057 of the $106,186 with a category attached, or 98.0%. AbbVie accounts for 98.4% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2021 at $69,272 and has fallen 99.5% since, to $335 in 2025. Among obstetrics & gynecology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $892.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$105K
- Bayer$352
- Organon$164
- Coopersurgical, Inc.$151
- Merck$143
- Exeltis, USA Inc.$123
- plus $743 from 20 others
What the payments were for
- Speaking & faculty fees$104,05798%
- Food & beverage$2,1302%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 38 | $104,509 |
| Bayer | 16 | $352 |
| Organon | 9 | $164 |
| Coopersurgical, Inc. | 8 | $151 |
| Merck | 3 | $143 |
| Exeltis, USA Inc. | 7 | $123 |
| Avion Pharmaceuticals | 6 | $91 |
| Mayne Pharma Commercial LLC | 3 | $65 |
| Shield Therapeutics Inc | 3 | $64 |
| Myriad Women's Health, Inc. | 1 | $60 |
| Astellas Pharma US Inc | 3 | $54 |
| Hologic Sales And Service, LLC | 4 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Therapeuticsmd, Inc. | 3 | $42 |
| Aroa Biosurgery Incorporated | 1 | $42 |
| Medicem Inc. | 1 | $32 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Exact Sciences | 1 | $26 |
| Novo Nordisk | 1 | $23 |
| Minerva Surgical, Inc | 1 | $22 |
| GSK | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Myovant Sciences Inc. | 1 | $18 |
| Sage Therapeutics, LLC | 1 | $16 |
| Pfizer | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GARDASIL$116
How this compares
$106,186 in reported general payments places this provider in the 95th percentile of 705 obstetrics & gynecology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol (Twice Weekly)Estradiol | 11 | $1,741 |
| Estradiol | 12 | $997 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Lonetree
- John CraneLoveland$415K
- James LukbanEnglewood$175K
- William BrownDenver$76K
- Kristina TocceDenver$57K
- Jill LissAurora$57K
- Alison CowanLouisville$32K
- Emily LandersLittleton$28K
- Marisa ToddDurango$28K
- Ronald GibbsAurora$28K
- Julie GelmanLittleton$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.